BICO Group
43,16 SEK +1,79%2 investorer følger denne virksomhed
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BICO
Daglig lav / høj pris
41,68 / 43,8
SEK
Markedsværdi
3,05 mia. SEK
Aktieomsætning
4,4 mio. SEK
Volumen
102 t
Seneste videoer
Finanskalender
Delårsrapport
20.08.2024
Delårsrapport
13.11.2024
Årsrapport
19.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Erik Gatenholm | 13,6 % | 20,5 % |
Sartorius AG | 10,1 % | 8,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Bulletin from Annual General Meeting in BICO Group AB (publ)
BICO publishes adjusted Annual and Sustainability Report 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools